Download full-text PDF |
Source |
---|
Crit Care Explor
October 2024
Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
J Intensive Care Med
August 2024
Department of Pharmacy, Massachusetts General Hospital, Boston, USA.
Background: Persistent vasopressor requirements are a common reason for delayed liberation from the intensive care unit (ICU) and adjunct oral agents are sometimes used to hasten time to vasopressor discontinuation. We sought to describe the use of droxidopa for vasopressor weaning in critically ill patients with prolonged hypotension.
Materials And Methods: This retrospective, single-arm, observational study included adult patients admitted to an ICU at two academic centers between 06/2016-07/2023 who received droxidopa for vasopressor weaning.
Front Bioeng Biotechnol
June 2024
Academy of Military Medical Sciences, Academy of Military Science of the Chinese People's Liberation Army, Beijing, China.
Red blood cell substitutes offer a solution to the problem of blood shortage and side effects of blood transfusion. Hemoglobin-based oxygen carriers (HBOCs) are one of the promising substitutes for red blood cells. Vasoactivity, which refers to the side effect of HBOCs that causes vasoconstriction and subsequent hypertension, limits the clinical application of HBOCs.
View Article and Find Full Text PDFCureus
June 2024
Department of Pulmonary Critical Care, Legacy Emanuel Medical Center, Portland, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!